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Adapting and disseminating effective public
health interventions in another country: towards
a systematic approach
Pim Cuijpers1,2, Ireen de Graaf2, Ernst Bohlmeijer2
Background: Public health interventions that have proven effective in one country, are often adapted
and disseminated in other countries. However, the process by which effective interventions are chosen
for adaptation and dissemination in another country is often not conducted systematically.Methods:We
propose a more systematic approach and describe the main steps that have to be taken in the assessment
of the usefulness of effective interventions in another national context. Results: The following steps are
proposed. Step 0: Point out themost relevant areas in public health (this is a collaborative effort by policy
makers, scientists and practitioners). Step 1: Identification of potentially effective interventions (through
systematic literature searches). Step 2: Assessing the levels of evidence and grades of recommendation
for adoption. Step 3: Can the results of the trials be generalized to the national situation? Step 4: Can the
intervention be implemented in the national situation? Conclusion: A more systematic approach to the
adaptation and dissemination can be adopted. The basic steps described should be worked out in more
detail before they can be used in practice.
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The process of deciding whether or not to implement apromising new public health technology has been well-
defined.1–4 However, public health interventions that have
proven effective in one country, are also often adapted and
disseminated in other countries where they have not been
examined. For example, in the area of psychosocial interven-
tions a wide array of interventions has been adapted for use in
other countries, such as the JOBS-programme (prevention of
psychosocial problems among the unemployed);5,6 the ‘Coping
with Depression’ course (prevention and early treatment of
depressive disorders;7–9 the Australian Triple P programme
(prevention and treatment of behaviour problems in chil-
dren);10,11 Communities that care (community programmes);12
the PATHS curriculum for prevention of psychosocial problems
at school;13,14 the Nurse Home Visitation for the prevention of
child abuse and neglect.15
Although the adaptation and dissemination of such interven-
tions in another country are common practice, the process by
which effective interventions are chosen for adaptation and
dissemination is often not conducted systematically. Whether a
new effective intervention is noticed depends very much on
researchers and practitioners in a specific area and whether they
keep up with the scientific literature in their field of study. It is
entirely possible that important interventions are not ‘discov-
ered’ in a country or only after a long time.
Furthermore, there are several methods and checklists to test
the quality of research examining the effects of an intervention
16,17 and to assess the innovative value.1–4 However, there are no
checklists to examine whether the contrast between experimen-
tal and control conditions examined in the international study,
is also meaningful in a national context. For example, it is very
well possible that a ‘care-as-usual’ condition in an American
study is very different from the ‘care-as-usual’ in another
country. In such a situation, the intervention should be
examined in a new trial in the national situation, before it can
be regarded as effective from a scientific point of view.
Also, interventions that have proven effective in one country
may not always be implementable in another country. For
example, the very strict ‘no use’ message in American
prevention programmes for illegal drugs, does not fit in the
public and professional opinions of several European countries.
Or community programmes that have been examined in the
communities of one country may not be useful in another
country because the character of the communities differ
strongly.
Because the resources for developing and examining public
health interventions are limited in most smaller countries, the
decision about which interventions are adapted to the national
or local situation should be taken as efficiently and rationally as
possible. It is, therefore, advisable to develop a more systematic
approach. In this paper we will describe the main steps that have
to be taken in the assessment of the usefulness of effective
interventions in another national context.
In table 1, we have summarized the main steps of this process
and important questions that have to be answered at each step.
The decisions that can be taken after each step and the possible
actions resulting from these decisions, are summarized in a
decision tree (figure 1).
Step 0. Point out the most relevant areas in
public health
Before interventions can be adopted in a country, it is advisable
to define the most relevant public health areas in the country.
The number of possible health care areas is very large, and it is
not possible to examine the literature on all of these areas, or
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examine the research, and conduct pilot projects. It is
possible, however, depending on the resources, to determine
a number of health care areas on which the next four basic
steps can be taken. In this step, scientists and policymakers
should collaborate and combine knowledge about the
prevalence and impact of health problems and political
priorities. The impact of many health problems has been
documented in most Western countries through various
epidemiological studies, such as the Global Burden of Disease
studies,18 and the replication of these studies for specific
countries. In prioritizing health problems the impact of this
problem on the number of disability adjusted life years in the
country should be one of the major criteria.
Step 1. Identification of potentially effective
interventions
The first step in the systematic assessment process is the
identification of effective interventions which may be useful in
another country. This step should be conducted through
systematic literature studies. It is necessary to define the area
which will be examined. For example, it is entirely feasible to
examine whether effective interventions are available in the area
of prevention of depression in adolescents, parent education, or
prevention of work-related problems. Usually the selection of
such areas will be conducted by financers of research and
treatment or prevention services, such as governments or
private funding agencies. The rules for conducting literature
searches have been developed well, especially in recent years,
through the work of the Cochrane Collaboration and other
evidence based initiatives.19
Step 2. Assessing the levels of evidence and grades of
recommendation for adoption
After identifying effect studies of interventions that may be
useful in other countries, it is important to assess the
strength of the evidence found in the trials examining the
intervention. Several levels of evidence have been described
elaborately in several studies, as well as several grades of
recommendation for the adoption of an intervention.1–4,20
Summarizing, these studies state that the evidence is stronger
when the best designs have been used (well-conducted
randomized controlled trials), when more studies have been
conducted on the same intervention and when these trials
have been integrated statistically into a meta-analysis. For the
adoption of a new intervention it is also important that the
cost-effectiveness has been examined in well-designed
studies.2
Based on this evidence it is possible to develop grades of
recommendation for the adoption of a new intervention. The
recommendation to adopt a new intervention is strongest
when the intervention has proven to be more effective than
Table 1 First draft of a checklist for assessing the possibilities
for adapting and disseminating effective public health
interventions in another country
Step 0. Point out the most relevant areas in public health
†What health problems have the most impact in terms
of daily adjusted life years.
†What is the prevalence of major health problems.
†Public demands for health care.
†For what problems is sufficient political support.
Step 1. Identification of potentially effective interventions
†Define the health care area and target for interventions.
†Search for randomized trials and systematic reviews
(and meta-analyses) in bibliographical databases,
such as Medline, Psychinfo, Embase, Eric, Dare and
the Cochrane Library.
†Use international standards in conducting
literature searches.
Step 2. Assessing the levels of evidence and grades
of recommendation for adoption
†Assess the quality of identified trials using one of
the widely available checklists.
†Pay special attention to four sources of bias (selection
bias; performance bias; attrition bias; detection bias.19
†When systematic reviews or meta-analyses are available,
also check the quality of these.
†Determine the level of evidence.2,4
†Determine the grade of recommendation for adoption.2
Step 3. Can the results of the trials be generalized
to the national situation?
†Is the health care system of the country where the trial
is conducted comparable to the country where it is
planned to be implemented, in terms of:
†The professional delivering the service or conducting
the intervention (expertise, training, resources, etc).
†The target population (demographic characteristics,
risk status).
†The health care system (the financing system, the costs
for the patient or care receiver, alternative
interventions available etc).
†And do national experts agree on this?
Step 4. Can the intervention be implemented in
the national situation?
†Are there any comparable interventions already used
in this area of health care?
†Is the problem seen by the professionals in the field
as a relevant problem, which they encounter often
in daily practice as a problem that costs much time
and resources or causes much human suffering?
†Do the professionals who have to conduct
the intervention have sufficient resources for conducting
this intervention, for example because the intervention
will replace another one, or can additional resources
be raised?
†Does the intervention result in efficiency raising for
the professionals who have to work with it or can it
improve the quality of the care?
†Is there enough political and managerial support for
the implementation of this intervention?
Figure 1 Decision tree for whether or not to disseminate an
effective intervention from one country to another
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the existing interventions or when the costs of the new
intervention are lower than the existing interventions.2 For
further information about the levels of evidence and the
grades of recommendation for the adoption, the reader is
referred to the many reviews and papers on this subject.1–4,20
Step 3. Can the results of the trials be generalized to
the national situation?
A fundamental problem in adapting an intervention to another
national situation, is the generalizability of the trial results.
Where medication is concerned, it is usually assumed that this is
applicable in different cultures, as the physiology of human
beings can be considered to be comparable. In public health
interventions this is not automatically the case and it is entirely
possible that there are fundamental differences. For example, it
may well be the case that the ‘care-as-usual’ used for a control
group in a US study differs strongly from the ‘care-as-usual’ in a
European country. The results of such a study are not
automatically useful in that European country. In that case a
new trial has to be conducted in that country to examine
whether this intervention is also effective in the other national
context.
There is no clear-cut method for examining whether the
results of international trials can be generalized to another
national situation. This can only be substantiated by consulting
national experts in the specific section of health care in which
the intervention is to be implemented. Only this information
can help in assessing whether the contrast of the international
trial is also relevant to the national situation.
This step needs to be considered explicitly by groups of
experts, as these are not issues for individual judgement. In
these expert panels, both experts from practice should
participate, as well as scientists and policymakers, as this is a
discussion which touches on all three fields. It would be useful
to develop a systematic description of the contrast examined in
the trial, and the practice in the national situation. The contrast
should be examined on three levels:
1. the professional delivering the service or conducting the
intervention (expertise, training, resources, etc);
2. the target population (demographic characteristics, risk
status);
3. the health care system (the financing system, the costs for the
patient or care receiver, alternative interventions available
etc).7
When the expert panel concludes that the results cannot be
automatically generalized to the other national situation, a new
national trial has to be conducted before broad dissemination of
the intervention can be considered. When the results are
generalizable, the next step can be taken.
Step 4. Can the intervention be implemented
in the national situation?
When the intervention can be considered to be effective in the
national situation, it has to be examined whether the
intervention can be implemented. In order to reach this
decision, the area of health care in which the intervention is
to be implemented must be examined carefully. For example, it
has to be clear that the professionals who will conduct the
intervention are motivated to do so and have sufficient
expertise, that sufficient resources for conducting the interven-
tion are available or can be made available. It may be possible
that comparable interventions are already in place on a large
scale and that the professionals do not see the need to replace
these.
Again, this is not an issue for individual judgement, and this
step should also be considered explicitly by a group of experts
from practice, science and policymakers. The question whether
the intervention is implementable should also be considered on
the same three levels as described in step 3: the level of the
professional delivering the new service (do they sufficient
knowledge and skills, time and resources to deliver the
intervention?); the individual level (will the intervention be
acceptable for the target population in this format?); and the
health care system (does the intervention fit into the health care
system in terms of financing, alternative interventions,
resources, priorities?).
When all signs seem to indicate that the intervention can be
implemented, it is advisable to translate the manuals and
materials, and to conduct some pilot projects in two or three
regions. This is the only way to discover practical problems and
further adaptation and improvement to the intervention. If
these pilot projects are successful, then there is no further
barrier for broad-scale implementation of the intervention in
the national situation.
If the conclusion is that the intervention cannot be
implemented in the national situation, it may be useful to
examine if the results of the trials can be used in other ways, for
example by adapting the contents of existing interventions.
Discussion
In this paper we argued that the decision whether an
intervention that has proven effective in one country should
be implemented in another country, has to be rationalised. We
proposed four basic steps that have to be taken before such an
intervention can be implemented in another country. Of course
we only made a first draft of a possible decision process. We
described basic elements, but this approach should be worked
out in detail before it can be used in practice.
Although our approach seems to be more rational than the ad
hoc methods that are now common practice, several problems
remain unsolved. First, this approach is based on the availability
of well-designed, randomized trials. In several important public
health areas, such as mass media campaigns, it is virtually
impossible to conduct randomized trials. Such interventions
may be very important and useful, but the effects cannot be
examined without major risks of bias. In this case the basic steps
of our approach, especially step 2, are problematic. Second,
when the basic steps are followed and the conclusion is that an
intervention can be implemented on a wide scale, it is never
certain whether the translation and the adaptations to the
national context have reduced the effectiveness of the interven-
tion. Therefore, one may argue that it is always advisable to
conduct a new trial examining the effects of the intervention in
the national context.
A major challenge for scientist and policymakers is to define
the areas of health care they consider to be the most important.
This is a complex enterprise, demanding policymakers and
scientist to work together closely. National Health Boards could
play a major role in this and several have developed systematic
strategies to prioritize health subjects and the development and
adoption of new interventions, as in the United Kingdom and in
The Netherlands. But this cannot be a one-off action. Public
health care is undergoing rapid development, and effective,
innovative interventions are appearing regularly. National
governments should reserve resources for defining the areas
they want to have screened for effective interventions, and for
repeating this action regularly, for example every year. This is
the only way to decide rationally which interventions should be
implemented in order to reduce the health problems that are
considered most important.
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Key points
† The adaptation and dissemination of an intervention
developed in one country in the context of another
country should be done in a more systematic way; we
propose a four-step approach.
† Step 0: Point out the most relevant areas in public
health (this is a collaborative effort by policy makers,
scientists and practitioners).
† Step 1: Identify potentially effective interventions
(through systematic literature searches).
† Step 2: Assess the levels of evidence and grades of
recommendation for adoption.
† Step 3: Can the results of the trials be generalized to the
national situation?
† Step 4: Can the intervention be implemented in the
national situation?
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